Global Antiemetics Market, Global Scenario, Market Size, Outlook, Trend, and Forecast, 2016 – 2025

TABLE OF CONTENTS

Chapter 1        Prefix

1.1    Market Scope

1.2    Report Description

1.3    Research Methodology

1.3.1     Primary Research

1.3.2     Secondary Research

1.3.3     In-house Data Modeling

Chapter 2        Executive Summary

2.1   Global Antiemetics Market Year-on-Year Growth, 2020 – 2028 (%)

Chapter 3        Market Outline

3.1    Market Inclination, Trend, Outlook and Viewpoint

3.2    Market Share Analysis: Company’s Competitive Scenario

3.3    Value Chain Analysis

3.4    Porter’s Five Forces Analysis

3.5    Market Dynamics

3.5.1     Drivers

3.5.1.1     Impact Analysis

3.5.2     Restraints

3.5.2.1     Impact Analysis

3.5.3     Opportunities

Chapter 4        Global Antiemetics Market by Application: Market Size and Forecast, 2019 – 2028

4.1    Overview

4.2  Chemotherapy – Induced Nausea and Vomiting

4.2.1   Current Trend and Analysis

4.2.2   Market Size and Forecast, 2019 - 2028 ($ Billion)

4.2.3   Market Size and Forecast by Region, 2019 - 2028 ($ Billion)

4.3  Gastroenteritis

4.3.1   Current Trend and Analysis

4.3.2   Market Size and Forecast, 2019 - 2028 ($ Billion)

4.3.3   Market Size and Forecast by Region, 2019 - 2028 ($ Billion)

4.4  Nausea and Vomiting of Pregnancy(NVP)

4.4.1   Current Trend and Analysis

4.4.2   Market Size and Forecast, 2019 - 2028 ($ Billion)

4.4.3   Market Size and Forecast by Region, 2019 - 2028 ($ Billion)

4.5  Post-Operative Nausea and Vomiting

4.5.1   Current Trend and Analysis

4.5.2   Market Size and Forecast, 2019 - 2028 ($ Billion)

4.5.3   Market Size and Forecast by Region, 2019 - 2028 ($ Billion)

Chapter 5        Global Antiemetics Market by Geography: Market Size and Forecast, 2019 - 2028 

5.1  Overview

5.1.1   Global Antiemetics Market Year-on-Year Growth, by region 2020 – 2028 (%)

5.2  North America

5.2.1   Current Trend and Analysis

5.2.2   Market Size and Forecast, 2019 - 2028 ($ Billion)

5.2.3   By Application

5.3    Europe

5.3.1   Current Trend and Analysis

5.3.2   Market Size and Forecast, 2019 - 2028 ($ Billion)

5.3.3   By Application

5.4    Asia-Pacific

5.4.1   Current Trend and Analysis

5.4.2   Market Size and Forecast, 2019 - 2028 ($ Billion)

5.4.3   By Application

5.5    RoW

5.5.1   Current Trend and Analysis

5.5.2   Market Size and Forecast

5.5.3   By Application

Chapter 6        Company Profiles   

6.1  Abott Laboratories

6.1.1     Company Overview

6.1.2     Product Portfolio

6.1.3     Business Strategies

6.1.4     Financials

6.1.5     Recent Developments

6.2  Astellas Pharma Inc.

6.2.1     Company Overview

6.2.2     Product Portfolio

6.2.3     Business Strategies

6.2.4     Financials

6.2.5     Recent Developments

6.3  Aphios Corp.

6.3.1     Company Overview

6.3.2     Product Portfolio

6.3.3     Business Strategies

6.3.4     Financials

6.3.5     Recent Developments

6.4  Aurobindo Pharma

6.4.1     Company Overview

6.4.2     Product Portfolio

6.4.3     Business Strategies

6.4.4     Financials

6.4.5     Recent Developments

6.5  Daiichi Sankyo Company Ltd.

6.5.1     Company Overview

6.5.2     Product Portfolio

6.5.3     Business Strategies

6.5.4     Financials

6.5.5     Recent Developments

6.6  Eisai Co., Inc.

6.6.1     Company Overview

6.6.2     Product Portfolio

6.6.3     Business Strategies

6.6.4     Financials

6.6.5     Recent Developments

6.7  GlaxoSmithKline PLC

6.7.1     Company Overview

6.7.2     Product Portfolio

6.7.3     Business Strategies

6.7.4     Financials

6.7.5     Recent Developments

6.8  Helsinn Healthcare SA

6.8.1     Company Overview

6.8.2     Product Portfolio

6.8.3     Business Strategies

6.8.4     Financials

6.8.5     Recent Developments

6.9  Heron Therapeutics, Inc.

6.9.1     Company Overview

6.9.2     Product Portfolio

6.9.3     Business Strategies

6.9.4     Financials

6.9.5     Recent Developments

6.10       IPCA Laboratories, Ltd.

6.10.1   Company Overview

6.10.2   Product Portfolio

6.10.3   Business Strategies

6.10.4   Financials

6.10.5   Recent Developments

6.11       KYOWA Hakka Kirin Pharma, Inc.

6.11.1   Company Overview

6.11.2   Product Portfolio

6.11.3   Business Strategies

6.11.4   Financials

6.11.5   Recent Developments

6.12       Merck & Co., Inc.

6.12.1   Company Overview

6.12.2   Product Portfolio

6.12.3   Business Strategies

6.12.4   Financials

6.12.5   Recent Developments

6.13       Novartis AG

6.13.1   Company Overview

6.13.2   Product Portfolio

6.13.3   Business Strategies

6.13.4   Financials

6.13.5   Recent Developments

6.14       F.Hoffmann – LA Roche AG

6.14.1   Company Overview

6.14.2   Product Portfolio

6.14.3   Business Strategies

6.14.4   Financials

6.14.5   Recent Developments

6.15       Sanofi Aventis

6.15.1   Company Overview

6.15.2   Product Portfolio

6.15.3   Business Strategies

6.15.4   Financials

6.15.5   Recent Developments

6.16       Tesaro, Inc.

6.16.1   Company Overview

6.16.2   Product Portfolio

6.16.3   Business Strategies

6.16.4   Financials

6.16.5   Recent Developments

6.17       Teva Pharmaceutical Industries Ltd.

6.17.1   Company Overview

6.17.2   Product Portfolio

6.17.3   Business Strategies

6.17.4   Financials

6.17.5   Recent Developments

Back to top

Payment Options

Single User $3897
Five User $5175
Enterprise $9135
Datapack $1299
Short Report: $1799